FindTrial
Sign In

Product Code: IPN60190

2 trials

Sponsors

Ipsen Bioscience, Inc.

Conditions

Adults patients with Primary Sclerosing Cholangitis (PSC) MedDRA version: 20.1 Level: LLT Classification code 10036732 Term: Primary sclerosing cholangitis System Organ Class: 100000004871Adults patients with Primary Sclerosing Cholangitis (PSC) MedDRA version: 20.1 Level: LLT Classification code 10036732 Term: Primary sclerosing cholangitis System Organ Class: 10019805 - Hepatobiliary disorders

Phase 2

A study on safety and efficacy of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis (PSC)
Active, not recruitingEUCTR2022-002695-37-DE
Ipsen Bioscience, Inc.Adults patients with Primary Sclerosing Cholangitis (PSC) MedDRA version: 20.1 Level: LLT Classification code 10036732 Term: Primary sclerosing cholangitis System Organ Class: 10019805 - Hepatobiliary disorders
Start: 2023-04-27Target: 60Updated: 2024-08-26
A study on safety and efficacy of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis (PSC)
Not yet recruitingEUCTR2022-002695-37-ES
Ipsen Bioscience, Inc.Adults patients with Primary Sclerosing Cholangitis (PSC) MedDRA version: 20.1 Level: LLT Classification code 10036732 Term: Primary sclerosing cholangitis System Organ Class: 100000004871
Start: 2023-02-13Target: 60Updated: 2023-02-20